Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 387,600 | 2,961,600 | 2,412,100 | 1,277,200 | 218,500 |
| Depreciation Amortization | 112,300 | 638,000 | 398,600 | 277,900 | 143,100 |
| Income taxes - deferred | -64,500 | -168,600 | -139,800 | -47,500 | 1,000 |
| Accounts receivable | 114,800 | -203,400 | -109,500 | -67,300 | -87,500 |
| Other Working Capital | -184,100 | -890,300 | 97,200 | 99,900 | -780,500 |
| Other Operating Activity | 89,200 | -953,000 | -1,099,300 | -641,900 | 667,200 |
| Operating Cash Flow | $455,300 | $1,384,300 | $1,559,300 | $898,300 | $161,800 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -66,600 | 342,300 | 428,700 | -94,800 | -57,900 |
| Net Acquisitions | N/A | N/A | 990,300 | N/A | N/A |
| Purchase Of Investment | -1,321,200 | -3,448,500 | -2,805,900 | -2,311,600 | -1,133,500 |
| Sale Of Investment | 440,500 | 4,661,300 | 3,104,700 | 1,461,500 | 543,600 |
| Purchase Sale Intangibles | -5,000 | -2,900 | -1,900 | -1,900 | 0 |
| Other Investing Activity | -5,700 | 21,500 | -100 | 990,400 | -200 |
| Investing Cash Flow | $-953,000 | $1,576,600 | $1,717,700 | $45,500 | $-648,000 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -1,002,200 | -1,002,200 | N/A | N/A |
| Common Stock Issued | N/A | N/A | -5,800 | -11,500 | N/A |
| Common Stock Repurchased | N/A | -750,000 | -750,000 | -500,000 | -20,800 |
| Other Financing Activity | -43,400 | 4,900 | 18,100 | 23,500 | 4,300 |
| Financing Cash Flow | $-43,400 | $-1,747,300 | $-1,739,900 | $-488,000 | $-16,500 |
| Exchange Rate Effect | 20,000 | -55,700 | -122,900 | -70,600 | -9,400 |
| Beginning Cash Position | 3,419,300 | 2,261,400 | 2,261,400 | 2,261,400 | 2,261,400 |
| End Cash Position | 2,898,200 | 3,419,300 | 3,675,600 | 2,646,600 | 1,749,300 |
| Net Cash Flow | $-521,100 | $1,157,900 | $1,414,200 | $385,200 | $-512,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | 455,300 | 1,384,300 | 1,559,300 | 898,300 | 161,800 |
| Capital Expenditure | -66,600 | -240,300 | -153,900 | -94,800 | -57,900 |
| Free Cash Flow | 388,700 | 1,144,000 | 1,405,400 | 803,500 | 103,900 |